ADVFN US – Market Content Editor

  • Tian Ruixiang in Advanced Talks on Asia-Pacific InsurTech Combination While Pursuing Bitcoin Acquisition Strategy

    Tian Ruixiang in Advanced Talks on Asia-Pacific InsurTech Combination While Pursuing Bitcoin Acquisition Strategy

    Tian Ruixiang Holdings Ltd (NASDAQ:TIRX) said it is in advanced, final-stage discussions regarding a potential strategic business combination with a leading insurance technology company operating across the Asia-Pacific region. The company also confirmed it continues to advance its previously announced strategy to acquire Bitcoin (BTC), part of a broader effort aimed at strengthening long-term shareholder…

  • Fortress Biotech to Receive $205M as Cyprium Agrees Sale of Rare Pediatric Disease Priority Review Voucher

    Fortress Biotech to Receive $205M as Cyprium Agrees Sale of Rare Pediatric Disease Priority Review Voucher

    Fortress Biotech, Inc. (NASDAQ:FBIO) said its majority-owned subsidiary Cyprium Therapeutics has signed a definitive agreement to sell a Rare Pediatric Disease Priority Review Voucher (PRV) for gross proceeds of $205 million, marking a significant monetization event following the recent FDA approval of ZYCUBO®. The voucher was granted after the U.S. Food and Drug Administration approved…

  • Gossamer Bio Shares Plunge After Phase 3 Trial Miss

    Gossamer Bio Shares Plunge After Phase 3 Trial Miss

    Gossamer Bio (NASDAQ:GOSS) shares dropped roughly 80% on Monday after the company announced that its investigational therapy seralutinib failed to achieve the primary endpoint in the Phase 3 PROSERA study targeting pulmonary arterial hypertension (PAH). The trial reported a placebo-adjusted improvement in Six-Minute Walk Distance (6MWD) of 13.3 meters at Week 24, with a p-value…

  • Atomera Shares Slide After $25M Registered Direct Offering Announcement

    Atomera Shares Slide After $25M Registered Direct Offering Announcement

    Atomera Incorporated (NASDAQ:ATOM) shares dropped 15% on Monday after the company disclosed plans for a $25 million registered direct offering of common stock. The semiconductor materials and technology licensing firm said it has entered into a securities purchase agreement with institutional investors to sell 5,000,000 shares priced at $5.00 each. The transaction is expected to…

  • Arcellx Shares Surge After Gilead Announces $7.8B Takeover Deal

    Arcellx Shares Surge After Gilead Announces $7.8B Takeover Deal

    Arcellx Inc. (NASDAQ:ACLX) shares soared 78.3% in premarket trading Monday after Gilead Sciences (NASDAQ:GILD) revealed plans to acquire the biotechnology company in a transaction valuing its equity at approximately $7.8 billion. Under the terms of the agreement, Arcellx shareholders will receive $115 per share in cash along with a contingent value right (CVR) worth up…

  • Reliance Global Group Shares Rally After Quantum Encryption Acquisition

    Reliance Global Group Shares Rally After Quantum Encryption Acquisition

    Reliance Global Group Inc. (NASDAQ:EZRA) shares surged 28% in premarket trading Monday after the company completed its acquisition of Enquantum Ltd., a developer of post-quantum cryptography technology. The transaction marks the first platform acquisition under Reliance’s EZRA Scale51 operating framework and creates a pathway for the company to obtain majority ownership of Enquantum. As part…

  • VenHub Shares Jump 20% After Launch of Self-Diagnostic Robotics Upgrade

    VenHub Shares Jump 20% After Launch of Self-Diagnostic Robotics Upgrade

    VenHub Global (NASDAQ:VHUB) shares climbed about 20% on Monday morning after the company unveiled new self-diagnostic features for the robotics powering its autonomous retail stores. The automated retail technology firm said key robotic components — including robotic arms, adaptive storage bins and smart refrigeration units — are now equipped with systems capable of detecting operational…

  • Vanda Pharmaceuticals Shares Surge Premarket Following FDA Approval of Bysanti

    Vanda Pharmaceuticals Shares Surge Premarket Following FDA Approval of Bysanti

    Shares of Vanda Pharmaceuticals (NASDAQ:VNDA) surged about 33% to $7.68 in premarket trading Monday after the company announced late Friday that the U.S. Food and Drug Administration had approved its drug Bysanti, sparking strong after-hours gains. The sharp move shifted investor focus to whether the rally can hold through regular trading, particularly after the stock…

  • A2Z Reports Q4 Revenue of Up to $5.2M Driven by Smart Cart Rollout

    A2Z Reports Q4 Revenue of Up to $5.2M Driven by Smart Cart Rollout

    A2Z Cust2Mate Solutions Corp. (NASDAQ:AZ) announced preliminary, unaudited revenue of between $4.6 million and $5.2 million for the fourth quarter ended December 31, 2025, according to a company press release. For the full year 2025, the company expects preliminary unaudited revenue in the range of $8.9 million to $9.5 million, representing growth compared with $7.46…

  • J-Star Signs Exclusive Global Distribution Agreement for Solid-State Batteries with PSSB

    J-Star Signs Exclusive Global Distribution Agreement for Solid-State Batteries with PSSB

    J-Star Holding Co., Ltd. (NASDAQ:YMAT) announced it has entered into an exclusive worldwide distribution agreement with Patriot Green Energy Technology covering PSSB’s solid-state battery products. Under the terms of the agreement, J-Star will act as the sole global distributor for PSSB’s solid-state batteries designed for electric-assist bicycles and electric motorcycles, according to a company press…